Tag: chemistry
-

Fox Foundation Funds New Genetic Variation Targets for Parkinson’s
A Parkinson’s disease organization is giving a grant to a neurodegenerative therapies developer that targets new groups of underlying disease-causing genetic changes.
-

RSV Vaccine Breakthrough Examined at AAAS Meeting
As three vaccines against respiratory syncytial virus reach FDA review, a scientific conference explored a key breakthrough researchers achieved to get to this point.
-

Business-Academic Team to Create RNA Delivery for Cancer
A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles.
-

mRNA Aerosol Delivered to Lungs to Treat Pneumonia
Messenger RNA, inhaled from an aerosol spray, is shown in lab rats with pneumonia to reduce inflammation, improve lung functions, and protect against further infections.
-

State Grant Supports Osteoarthritis Gene Therapy Trial
A California state agency is funding a clinical trial of an experimental gene therapy for reducing inflammation in knee joints of people with osteoarthritis.
-

Biotech to Synthesize Proteins in Microgravity
A biotechnology company synthesizing pure proteins from DNA is preparing to test its process in weightless conditions on the International Space Station.
-

Biotech Drug Shown to Kill Prostate Tumor Cells
Tests with lab mice show low doses of an experimental oral drug can selectively kill prostate cancer cells while not affecting surrounding healthy tissue.
-

Green Energy Chemical Company Starts-Up, Raises $15M
A new enterprise, spun-off from labs at Northwestern University, says it’s designing electrochemical processes and systems for nanoscale materials to help meet the climate crisis.
-

Allergy Antibody Biotech Gains $40M in New Funds
A biotechnology enterprise creating engineered antibodies to treat severe food allergies is raising $40 million in its second venture financing round.
-

Light-Activated Treatment Kills Covid-19 Nasal Viruses
Clinical trial findings show a light-activated disinfectant process kills SARS-CoV-2 viruses in the nose causing Covid-19 infections without harming nasal tissue.